⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
globenewswire.com
CRVO
CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies
globenewswire.com
CRVO
CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer
globenewswire.com
CRVO
CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
globenewswire.com
CRVO